YR5-86833-80017 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-23
Registered in v-safe
2020-12-23
Dose 1 — Pfizer-BioNTech
2021-01-13
Dose 2 — Pfizer-BioNTech
2021-01-27
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-03
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-10
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-17
Survey response — day 35, dose 2
MedDRA: Abortion spontaneous — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Miscarriage of pregnancy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-17
Report sent to call center — day 35, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-24
Survey response — day 42, dose 2
MedDRA: Abortion spontaneous — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Miscarriage of pregnancy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-24
Report sent to call center — day 42, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-14
Call 1 — Left Voicemail
2021-04-15
Survey response — 3 months, dose 2
MedDRA: Colitis ulcerative, Pre-existing disease, Rheumatoid arthritis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Flare of autoimmune conditions - ulcerative colitis and rheumatoid arthritis

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-15
Report sent to call center — 3 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-16
Call 1 — Left Voicemail
2021-07-16
Survey response — 6 months, dose 2
MedDRA: Immunosuppressant drug therapy, Pre-existing disease, Rheumatoid arthritis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Flare in rheumatoid arthritis necessitating initiation of immunosuppressive therapy

MedDRA releases: 2024-11 · check-in free text available
2021-07-16
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-23
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-23	Pfizer-BioNTech
2	2021-01-13	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-02-17	Unsuccessful
2021-02-24	Unsuccessful
2021-04-15	Unsuccessful
2021-07-16	Unsuccessful

Free text

Release 4 — day 35, dose 2

2021-02-17

Symptoms: Miscarriage of pregnancy

Release 4 — day 42, dose 2

2021-02-24

Symptoms: Miscarriage of pregnancy

Release 7 — 3 months, dose 2

2021-04-15

Symptoms: Flare of autoimmune conditions - ulcerative colitis and rheumatoid arthritis

Release 9 — 6 months, dose 2

2021-07-16

Symptoms: Flare in rheumatoid arthritis necessitating initiation of immunosuppressive therapy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abortion spontaneous	✓	✓	✓
SD	Colitis ulcerative	✓	✓	✓
SD	Immunosuppressant drug therapy	·	·	✓
SD	Pre-existing disease	✓	✓	✓
SD	Rheumatoid arthritis	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release